TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 81 filers reported holding TCR2 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,260 | +50.2% | 840 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $839 | -58.0% | 840 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $2,000 | 0.0% | 840 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,000 | 0.0% | 840 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $2,000 | -50.0% | 840 | 0.0% | 0.00% | -66.7% |
| Q4 2021 | $4,000 | -63.6% | 840 | -37.1% | 0.00% | -62.5% |
| Q3 2021 | $11,000 | -35.3% | 1,335 | +28.4% | 0.01% | -33.3% |
| Q2 2021 | $17,000 | -29.2% | 1,040 | -5.9% | 0.01% | -36.8% |
| Q1 2021 | $24,000 | – | 1,105 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 3,370,982 | $68,498,000 | 16.50% |
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $82,314,000 | 15.35% |
| Consonance Capital Management LP | 1,509,819 | $30,680,000 | 3.74% |
| Soleus Capital Management, L.P. | 282,041 | $5,731,000 | 3.04% |
| Redmile Group, LLC | 2,793,288 | $56,760,000 | 1.04% |
| PFM Health Sciences, LP | 775,794 | $15,764,000 | 0.73% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,200,000 | $24,384,000 | 0.59% |
| Cormorant Asset Management, LP | 600,000 | $12,192,000 | 0.47% |
| Sofinnova Investments, Inc. | 173,028 | $3,516,000 | 0.26% |
| Artal Group S.A. | 500,000 | $10,160,000 | 0.25% |